Historical record - last NADAC effective date: 3/19/2014
Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1869 per EA under NDC 55111025090. Its NADAC has been published 18 times since Nov 28, 2013.
FDA first approved this application on Jul 2, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111025090
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/19/2014
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076390FDA Approved
7/2/2007
TE Code
AB
On Market Since
7/2/2007
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 18 times since Nov 28, 2013, and over the history we have for it it has risen 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1869 per EA |
|---|---|
| All-time high | $0.1869 (Mar 26, 2014) |
| All-time low | $0.1563 (Nov 28, 2013) |
| Median price | $0.1825 |
| Average price | $0.1780 |
| Largest weekly change | +14.2% (Dec 18, 2013) |
| Weeks tracked | 18 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+19.6%
Last surveyed Mar 26, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Terbinafine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Allylamine Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1869 per EA (NDC 55111025090), effective Mar 26, 2014.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has risen 19.6%. It has been tracked across 18 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1563 (Nov 28, 2013) to a high of $0.1869 (Mar 26, 2014), with a median of $0.1825 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TERBINAFINE HCL 250 MG TABLET, is $0.1426 per EA — about 24% below TERBINAFINE HCL 250 MG TABLET.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 55111025090) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.